About Gibraltar Laboratories
Gibraltar Laboratories is a Healthcare company based in Fairfield (United States) founded in 1970, and was acquired by Sterigenics in August 2018. Bio-analytical and sterilization services are provided to clients. Its chief executive, as recorded, is Daniel Prince. The company was acqui-hired. Its focus areas include Life Sciences, Life Sciences Platforms and Tools, Research Services and Analytical Testing. Its competitors include Evelo Biosciences, PathogenDX and Phylos Bioscience; 3 of its 3 listed competitors have raised funding.
Company details
Gibraltar Laboratories was founded in 1970 and is based in Fairfield, United States. Operations focus on the biotechnology sector, with services encompassing analytical chemistry, environmental monitoring, microbiology, sterilization, validations and calibrations, virology, and molecular biology. Manufacturing facilities are certified under ISO standards, supporting bio-analytical needs across various applications.
- Headquarters Fairfield, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website gibraltarlabsinc.com
- Social LinkedIn X Facebook
- Acquired by Sterigenics (Aug 2018)
- Investors
- Acquired bySterigenics
(Aug 2018)
Investors in Gibraltar Laboratories
Gibraltar Laboratories has secured backing from 1 investor. Prominent investors backing the company include Sterigenics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Provider of comprehensive sterilization solutions and expert consulting services | 1978 | sterigenics.com | Oak Brook, United States |
Investor details for Gibraltar Laboratories
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Gibraltar Laboratories
1 people are tracked at Gibraltar Laboratories (1 in leadership).
| Name | Role | Group |
|---|---|---|
Daniel Prince | CEO & President | Leadership |
Complete people profiles for Gibraltar Laboratories
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of Gibraltar Laboratories
2 dated milestones of Gibraltar Laboratories across 48 years, from founding to its latest funding, stage changes and deals.
- Founded Gibraltar Laboratories is founded.
- Exit Acquired by Sterigenics.
Competitors of Gibraltar Laboratories
Gibraltar Laboratories has 3 listed competitors in our database, 3 of them funded. They include Evelo Biosciences, PathogenDX and Phylos Bioscience.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| evelobio.com | 2015 | Cambridge, United States | $166.5M | 117 | Therapeutics for inflammatory diseases, COVID-19, and cancer are developed. | |
| pathogendx.com | 2014 | Tucson, United States | $11.58M | 31 | Provider of DNA-based pathogen testing kits | |
| phylos.bio | 2014 | Portland, United States | $28.41M | 61 | Developer of cannabis breeding tools for agriculture & other health purposes |
Detailed competitors of Gibraltar Laboratories
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of Gibraltar Laboratories
Websites that share an audience with Gibraltar Laboratories (gibraltarlabsinc.com).
Websites whose visitors overlap most with Gibraltar Laboratories. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| caslab.com | 82% | 3.8K | #4,682,986 | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Gibraltar Laboratories (Life Sciences Platforms & Tools) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | |||
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | 1,111 | ||
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Gibraltar Laboratories
Complete news archive for Gibraltar Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Gibraltar Laboratories
Gibraltar Laboratories was founded in 1970.
Gibraltar Laboratories is headquartered in Fairfield, United States.
Daniel Prince is the CEO of Gibraltar Laboratories, as recorded in our data.
Gibraltar Laboratories was founded in 1970 and is based in Fairfield, United States. Operations focus on the biotechnology sector, with services encompassing analytical chemistry, environmental monitoring, microbiology, sterilization, validations and calibrations, virology, and molecular biology. Manufacturing facilities are certified under ISO standards, supporting bio-analytical needs across various applications.
Gibraltar Laboratories's top competitors include PathogenDX, Evelo Biosciences and Phylos Bioscience.
Gibraltar Laboratories has 1 investor. Key investors include Sterigenics.
Yes. Gibraltar Laboratories was acquired by Sterigenics in August 2018.